InsiderTrades

Form 4 for PGNY Progyny, Inc.

Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001628280-23-002774 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-08 2023-02-06 PGNY Schlanger David J Executive COB, Dir M - OptEx $0.91 +5,824 82.0K +8% +$5,300
D 2023-02-08 2023-02-06 PGNY Schlanger David J Executive COB, Dir S - Sale+OE $35.26 -5,824 76.2K -7% -$205.4K
D 2023-02-08 2023-02-06 PGNY Schlanger David J Executive COB, Dir M - OptEx $0.00 -5,824 925.1K -0.6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-06 M A 5,824 $0.91 81,992 D — —
2 Common Common Stock 2023-02-06 S D 5,824 $35.26 76,168 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Stock Option (Right to Buy) 2023-02-06 M D 5,824 $0.00 925,119 D $0.91 · — to 2027-08-03 5,824 Common Stock (F3) These options are fully vested and exercisable.